Navigation Links
Study reveals mass migration of mormon crickets driven by hunger, fear

An international team of researchers, including Kent State University professor Dr. Patrick D. Lorch, have revealed the motivating factors behind the seasonal mass migration of Mormon crickets in western North America.

The scientists report hunger for protein and salt, and a fear of cannibalism, drives the mass migration of Mormon crickets in western North America.

Throughout their seasonal migration, millions of Mormon crickets (relatives of locusts and grasshoppers) cover more than 50 miles of ground, destroying farmland and causing hazardous driving conditions along the way.

The research team, led by Dr. Stephen J. Simpson, conducted field observations and experimentation to determine that two driving forces are behind the migration: a need for protein and a fear of cannibalism.

Their results reveal a different model for collective motion, with the crickets' migration in effect a forced march. The constant threat of cannibalism from the rear appears to push the crickets' movement as much as the need to find protein and salt pulls it, researchers say.

The team's findings could lead to more environmentally friendly tactics for controlling large swarms of insects.


'"/>

Source:Kent State University


Page: 1

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
3. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
4. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
5. Study Links Ebola Outbreaks To Animal Carcasses
6. Breakthrough Microarray-based Technology for the Study of Cancer
7. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
8. Study finds more than one-third of human genome regulated by RNA
9. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
10. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
11. New Study from Affymetrix Laboratories Points to Changing View of How Genome Works
Post Your Comments:
(Date:5/16/2008)...he sugars attached to a hormone produced in the pi...early 50 percent, a research group at Washington U...d. The change appears to alter a reproductive "the...y system that may one day be used to enhance human... key reproductive hormones such as estrogen and te...
(Date:5/16/2008)...ata show that CAPHOSOL ( www.caphosol.com ), an ad... mucositis (OM) and improves quality of life for c...on therapy. These data will be reported in two se...presentation and one tomorrow as a poster session,...ng Society (ONS). These data confirm that CAPHOSOL...
(Date:5/16/2008)...al of Forest Research presents the preliminary fin...t landscape-scale experiments on how forest manage... The Blacks Mountain Interdisciplinary Research t...niversity, Oregon State University, U.C. Riverside...Society scientists collaborating in research on la...
(Date:5/16/2008)...rm-free homes for their children have led to an ev...i-bacterial soaps and cleaning agents. But the act... come under scrutiny by the EPA and FDA, due to bo...Two closely related antimicrobials, triclosan and ...ereas triclosan (TCS) has long captured the attent...
Breaking Biology News(10 mins):Disabling mouse enzyme increases fertility 2CAPHOSOL relieves oral mucositis and improves quality-of-life in cancer patients 2CAPHOSOL relieves oral mucositis and improves quality-of-life in cancer patients 3CAPHOSOL relieves oral mucositis and improves quality-of-life in cancer patients 4Pioneering landscape-scale research releases first findings 2New study links fate of personal care products to environmental pollution and human health concerns 2New study links fate of personal care products to environmental pollution and human health concerns 3DuPont Licenses Breakthrough Automotive Coating Technology to German Paint Maker 9628 1DuPont Licenses Breakthrough Automotive Coating Technology to German Paint Maker 9628 22008 Presidential Campaign on the Couch 9623 12008 Presidential Campaign on the Couch 9623 2VIA Pharmaceuticals Names Rebecca Taub Senior Vice President of Research and Development 2611 1VIA Pharmaceuticals Names Rebecca Taub Senior Vice President of Research and Development 2611 2VIA Pharmaceuticals Names Rebecca Taub Senior Vice President of Research and Development 2611 3VIA Pharmaceuticals Names Rebecca Taub Senior Vice President of Research and Development 2611 4Siemens Healthcare Diagnostics Launches B12 Folate and Ferritin Tests on Its Dimension vista Intelligent Lab System 1210 1Siemens Healthcare Diagnostics Launches B12 Folate and Ferritin Tests on Its Dimension vista Intelligent Lab System 1210 2Siemens Healthcare Diagnostics Launches B12 Folate and Ferritin Tests on Its Dimension vista Intelligent Lab System 1210 3
...cades to determine the chemical composition of sam...es, and never in complex environmental samples. ,... of Public Health recently demonstrated that prote...lied for this purpose. Using a two-step process, r...ncentrated a norovirus surrogate from a clinical s...
...size changes of Kiwis, Tuatara and other New Zeala...continually studied by conservationists and scient...in the viruses that infect them. , Dr Alexei Drum... Science, has been part of a global research team ...als. , This pioneering technique has so far prov...
... Research Associate at the Stowers Institute for M...ers Institute Investigator and an investigator wit...trated that the long-studied family of transcripti...ashion during the formation of the vertebral precu...gs, which were published in the March 7 issue of D...
...n cultures and in most mammals, males are usually ...t,s simple to blame male hormones, like testostero...e it,s in our genes, too. , Indeed such social beh...esearch on mice by neuroscientists at the Universi... sex chromosomes, XX versus XY, are also responsib...
Other Biology News:Ancient ants arose 140-168 million years ago 2Finding a virus is not all bad news 2Stowers scientists demonstrate mechanism of vertebral formation 2Sex chromosome genes influence aggression andmaternal behavior, say UVa researchers 2
(Date:5/16/2008)..., May 16 /- Alba Therapeutics Corpora...omized its first patient in a,twelve-week Phase II... of,intestinal barrier dysfunction, for the treatm...he global multi-center, randomized, double-blind,...l and histological,efficacy, safety and tolerabili...
(Date:5/16/2008)...May 16 / Oncolytics Biotech...t an abstract covering interim,results of a Phase ...th,sarcomas metastatic to the lung is available on...website at http://www.asco.org and on the Oncoly.... The abstract is entitled "A Phase II,Study of In...
(Date:5/15/2008)...J. and EMERYVILLE, Calif., May 16 /PRNewswire-Firs...nd Onyx Pharmaceuticals, Inc.,(Nasdaq: ONXX ) tod...e 2008,American Society of Clinical Oncology (ASCO...exavar(R) (sorafenib) tablets in multiple tumor ty... agents., "Data at ASCO will expand upon and supp...
(Date:5/15/2008)...ogy researchers at UC Davis have shown that they c...nstrument, an atomic force microscope. , "It tur...ology to calibrate an instrument," said Volkmar He...iomedical Engineering at UC Davis and co-author of..., An atomic force microscope uses a tiny lever t...
Breaking Biology Technology:Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease 2Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease 3Oncolytics Biotech Inc. Collaborators to Present Phase II Sarcoma Trial Results at ASCO Annual Meeting 2Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting 2Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting 3Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting 4Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting 5Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting 6Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting 7
...anagement , a developer of databases and healthcar...customer relationship management solution has been...alth. , ,St. John used the CRM solution to promot...n,s Comprehensive Cancer Center, a 15-year partner...arket research said the partnership had a lot of p...
...ay announced that three Wisconsin businesses would...ts from the Department of Commerce Technology Assi...F) Programs. , ,The projects are as follows: , , ...ny established in 2003 to provide DNA sequencing. ...sary to commercialize its proprietary DNA sequenci...
...College is launching a major effort to improve the...nical colleges and high schools. The initiative wi...g tools and other resources to better prepare qual...wable energy industry. , ,A $500,000 National Scie... MATC has announced in the past month - will fund ...
...ly chain technology provider, reported Friday that...eorge-based division of Cooper Industries, to opti...ductivity. , ,The lighting manufacturer is replaci...DLx Warehouse, slotting and workforce performance ...application will provide improved picking and puta...
Other Biology Technology:
Myt 1 (N-17)
Request Info
...agon-like peptide-1(7-36) amide (GLP-1), C-termina...ide but shows <0.1% cross reactivity with the unam...related peptides such as hGLP-2, glucagon, hGIP an...ies. GLP-1 is identical in all mammalian species s...
Anti Human JAM-1, Monoclonal Antibody, Clone M.Ab.F11
Biology Products: